Molassamide, a Depsipeptide Serine Protease Inhibitor from the Marine Cyanobacterium Dichothrix utahensis
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
A new dolastatin 13 analogue, molassamide (1), was isolated from cyanobacterial assemblages of Dichothrix utahensis collected from the Molasses Reef, Key Largo, Florida, and from Brewer's Bay, St. Thomas, U.S. Virgin Islands. This is the first peptide reported from the cyanobacterial genus Dichothrix and the first natural product isolated from marine Dichothrix spp. Its planar structure was determined by NMR spectroscopic techniques, and the configurations of the asymmetric centers were assigned after chiral HPLC analysis of the hydrolysis products. The depsipeptide 1 exhibited protease-inhibitory activity, with IC(50) values of 0.032 and 0.234 muM against elastase and chymotrypsin, respectively. There was no apparent inhibition of trypsin at 10 microM, the highest concentration tested.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Bioactive natural products from marine cyanobacteria for drug discovery
Tan, L. T. (2007) · Phytochemistry · doi:10.1016/j.phytochem.2007.01.012 · Cited by 534
Blunt, J. W., Copp, B. R., Hu, W.-P., Munro, M. H. G., Northcote, P. T., & Prinsep, M. R. (2009) · Natural Product Reports · doi:10.1039/b805113p · Cited by 520
Berry, J., Gantar, M., Perez, M., Berry, G., & Noriega, F. (2008) · Marine Drugs · doi:10.3390/md6020117 · Cited by 231
Chemical Defenses: From Compounds to Communities
Paul, V. J., Arthur, K. E., Ritson-Williams, R., Ross, C., & Sharp, K. (2007) · The Biological Bulletin · doi:10.2307/25066642 · Cited by 206
Self-citationSymplostatin 2: A Dolastatin 13 Analogue from the Marine Cyanobacterium Symploca hydnoides
Harrigan, G. G., Luesch, H., Yoshida, W. Y., Moore, R. E., Nagle, D. G., & Paul, V. J. (1999) · Journal of Natural Products · doi:10.1021/np980553b · Cited by 148
Self-citationLyngbyastatins 5–7, Potent Elastase Inhibitors from Floridian Marine Cyanobacteria, Lyngbya spp.
Taori, K., Matthew, S., Rocca, J. R., Paul, V. J., & Luesch, H. (2007) · Journal of Natural Products · doi:10.1021/np0702436 · Cited by 132
Self-citationKaltenbock, E., & Herndl, G. J. (1992) · Marine Ecology Progress Series · doi:10.3354/meps087147 · Cited by 107
Matthew, S., Ross, C., Rocca, J. R., Paul, V. J., & Luesch, H. (2007) · Journal of Natural Products · doi:10.1021/np060471k · Cited by 106
Self-citationPettit, G. R., Kamano, Y., Herald, C. L., Dufresne, C., Cerny, R. L., Herald, D. L., Schmidt, J. M., & Kizu, H. (1989) · Journal of the American Chemical Society · doi:10.1021/ja00195a084 · Cited by 82
Kwan, J. C., Taori, K., Paul, V. J., & Luesch, H. (2009) · Marine Drugs · doi:10.3390/md7040528 · Cited by 81
Self-citation
Research works printed but not linked: 2
- Araya-Maturana R., 2008, Nat. Prod. Commun., 3, 445
- Littler D. S., 2000, Caribbean Reef Plants
Cited by
Faulkner, D. J. (1990) · Natural Product Reports · doi:10.1039/np9900700269 · Cited by 4,866
Blunt, J. W., Copp, B. R., Keyzers, R. A., Munro, M. H. G., & Prinsep, M. R. (2012) · Nat. Prod. Rep. · doi:10.1039/c2np00090c · Cited by 482
Mayer, A., Rodríguez, A., Taglialatela-Scafati, O., & Fusetani, N. (2013) · Marine Drugs · doi:10.3390/md11072510 · Cited by 436
Natural product isolation – how to get from biological material to pure compounds
Bucar, F., Wube, A., & Schmid, M. (2013) · Natural Product Reports · doi:10.1039/c3np20106f · Cited by 373
Natural Products from Cyanobacteria: Focus on Beneficial Activities
Demay, J., Bernard, C., Reinhardt, A., & Marie, B. (2019) · Marine Drugs · doi:10.3390/md17060320 · Cited by 324
Cyanobacterial bioactive metabolites—A review of their chemistry and biology
Huang, I.-S., & Zimba, P. V. (2019) · Harmful Algae · doi:10.1016/j.hal.2018.11.008 · Cited by 181
α,β-Dehydroamino acids in naturally occurring peptides
Siodłak, D. (2014) · Amino Acids · doi:10.1007/s00726-014-1846-4 · Cited by 154
“2010), and molassamides B (cyanobacteria Dichothrix utahensis) (Gunasekera et al. 2010) can also be perceived as a family of compounds 10.”
BackgroundMarine cyanobacteria compounds with anticancer properties: A review on the implication of apoptosis
Costa, M., Costa-Rodrigues, J., Fernandes, M. H., Barros, P., Vasconcelos, V., & Martins, R. (2012) · Marine Drugs · doi:10.3390/md10102181 · Cited by 147
“As expected, these metabolites are chymotrypsin inhibitors [91,106].”
BackgroundInfluentialTargeting COPD: advances on low‐molecular‐weight inhibitors of human neutrophil elastase
Lucas, S. D., Costa, E., Guedes, R. C., & Moreira, R. (2011) · Medicinal Research Reviews · doi:10.1002/med.20247 · Cited by 107
Cyanobacterial bioactive metabolites—A review of their chemistry and biology
Huang, I., & Zimba, P. V. (2019) · Harmful Algae · doi:10.1016/j.hal.2019.05.001 · Cited by 106
A review of pharmacological and toxicological potentials of marine cyanobacterial metabolites
Nagarajan, M., Veerabadhran, M., & Sundararaman, M. (2011) · Journal of Applied Toxicology · doi:10.1002/jat.1717 · Cited by 101
“Lyngbya, Oscillatoria, Symploca, Calothrix, Leptolyngbya, Dichothrix, Geitlerinema, Schizothrix, Aphanothece, Blennothrix, Synechocystis) produce diverse structural classes of metabolites such as acyclic peptides, linear decadepsipeptides, linear lipopeptides, linear alkynoic lipopeptides, cyclic depsipeptides, cyclic…”
BackgroundMiller, B. W., Friedman, A. J., Choi, H., Hogan, J., McCammon, J. A., HOOK, V. Y. H., & Gerwick, W. H. (2013) · Journal of Natural Products · doi:10.1021/np400727r · Cited by 74
New Peptides Isolated from Marine Cyanobacteria, an Overview over the Past Decade
Mi, Y., Zhang, J., He, S., & Yan, X. (2017) · Marine Drugs · doi:10.3390/md15050132 · Cited by 82
Marine Cyanobacteria: A Source of Lead Compounds and their Clinically-Relevant Molecular Targets
Tan, L. T., & Phyo, M. Y. (2020) · Molecules · doi:10.3390/molecules25092197 · Cited by 65
Favas, R., Morone, J., Martins, R. F., Vasconcelos, V. M., & Lopes, G. (2021) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2021.1960830 · Cited by 70
“Molassamide Dichothrix utahensis PPE Gunasekera et al.(62) Scyptolins A and B Scytonema hofmanni PPE Matern et al.”
BackgroundExploring Marine Cyanobacteria for Lead Compounds of Pharmaceutical Importance
Uzair, B., Tabassum, S., Rasheed, M., & Rehman, S. F. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/179782 · Cited by 61
“One prevalent class found in marine and freshwater cyanobacteria is comprised of protease inhibitors with a cyclic depsipeptide scaffold that contains a 3-amino-6-hydroxy-2piperidone (Ahp) moiety as a key feature for inhibition of certain serine proteases [27].”
BackgroundKeller, L., Canuto, K. M., Liu, C., Suzuki, B. M., Almaliti, J., Sikandar, A., Naman, C. B., Glukhov, E., Luo, D., Duggan, B. M., et al. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.9b00992 · Cited by 58
Self-citationNative metabolomics identifies the rivulariapeptolide family of protease inhibitors
Reher, R., Aron, A. T., Fajtová, P., Stincone, P., Wagner, B., Pérez-Lorente, A. I., Liu, C., Shalom, I. Y. B., Bittremieux, W., Wang, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32016-6 · Cited by 53
Biotechnological exploitation of cyanobacteria and microalgae for bioactive compounds
Singh, S. K., Kaur, R., Bansal, A., Kapur, S., & Sundaram, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-444-64323-0.00008-4 · Cited by 66
Sebestenoids A–D, BACE1 inhibitors from Cordia sebestena
Dai, J., Sorribas, A., Yoshida, W. Y., & Williams, P. G. (2010) · Phytochemistry · doi:10.1016/j.phytochem.2010.09.008 · Cited by 48
“The compounds were assayed against the serine protease chymotrypsin in a standard chemiluminescent assay (Gunasekera et al., 2010) with and without the addition of detergent.”
MethodRubio, B. K., Parrish, S. M., Yoshida, W. Y., Schupp, P. J., Schils, T., & Williams, P. G. (2010) · Tetrahedron Letters · doi:10.1016/j.tetlet.2010.10.062 · Cited by 46
Peptide Human Neutrophil Elastase Inhibitors from Natural Sources: An Overview
Marinaccio, L., Stefanucci, A., Scioli, G. A., Valle, A. D., Zengin, G., Cichelli, A., & Mollica, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23062924 · Cited by 51
“who elucidated its structure and inhibitory activity against porcine pancreatic elastase, α-chymotrypsin from bovine pancreas and trypsin from porcine pancreas (Figure 6) [36].”
BackgroundKöcher, S., Resch, S., Kessenbrock, T., Schrapp, L., Ehrmann, M., & Kaiser, M. (2020) · Natural Product Reports · doi:10.1039/c9np00033j · Cited by 41
The Natural Polypeptides as Significant Elastase Inhibitors
Ahmad, S., Saleem, M., Riaz, N., Lee, Y. S., Diri, R. M., Noor, A. O., Almasri, D. M., Bagalagel, A. A., & Elsebai, M. F. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00688 · Cited by 44
“Compound 57 exhibited potent June 2020 | Volume 11 | Article 688 Frontiers in Pharmacology | www.frontiersin.org June 2020 | Volume 11 | Article 68810 protease-inhibition activity, with IC50 0.03 and 0.23 µM against PPE and chymotrypsin, respectively (Gunasekera et al., 2010).”
BackgroundInfluentialA critical review on marine serine protease and its inhibitors: A new wave of drugs?
Barzkar, N., Khan, Z., Jahromi, S. T., Pourmozaffar, S., Gozari, M., & Nahavandi, R. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.12.134 · Cited by 44
Therapeutic Potential of Marine Peptides in Prostate Cancer: Mechanistic Insights
Ahmed, S., Alam, W., Jeandet, P., Aschner, M., Alsharif, K. F., Saso, L., & Khan, H. Z. (2022) · Marine Drugs · doi:10.3390/md20080466 · Cited by 39
A Review of the Antimicrobial Properties of Cyanobacterial Natural Products
Cock, I. E., & Cheesman, M. J. (2023) · Molecules · doi:10.3390/molecules28207127 · Cited by 42
“In a different study, molassamide was isolated from the cyanobacterium Dichothrix utahensis , making it the first natural product identified in any species from the genus Dichothrix [82].”
BackgroundProgress in the discovery and development of anticancer agents from marine cyanobacteria
Luesch, H., Ellis, E. K., Chen, Q.-Y., & Ratnayake, R. (2024) · Natural Product Reports · doi:10.1039/d4np00019f · Cited by 43
Self-citationKowser, Z., Tomiyasu, H., Jiang, X., Rayhan, U., Redshaw, C., & Yamato, T. (2015) · New Journal of Chemistry · doi:10.1039/c4nj02363c · Cited by 36
Marine Organisms as a Prolific Source of Bioactive Depsipeptides
Zeng, M., Tao, J., Xu, S., Bai, X., & Zhang, H. (2023) · Marine Drugs · doi:10.3390/md21020120 · Cited by 36
“Molassamide (76) was the first depsipeptide reported from the marine cyanobacterial genus Dichothrix and has protease inhibitory activity [47].”
BackgroundWhitton, B. A., & Mateo, P. (2012) · Springer eBooks · doi:10.1007/978-94-007-3855-3_22 · Cited by 36
Al‐Awadhi, F. H., Paul, V. J., & Luesch, H. (2018) · ChemBioChem · doi:10.1002/cbic.201700627 · Cited by 35
Self-citationTotal Synthesis and Antimicrobial Activity of a Natural Cycloheptapeptide of Marine Origin
Dahiya, R., & Gautam, H. (2010) · Marine Drugs · doi:10.3390/md8082384 · Cited by 34
“tert-Butyloxycarbonyl-L-prolyl-L-isoleucyl-L-prolyl-L-phenylalanyl-L-prolyl-L-prolyl-L-tyrosine methyl ester (7).”
MethodChemical diversity of cyanobacterial natural products
Weiss, M. B., Borges, R. M., Sullivan, P., Domingues, J. P. B., da Silva, F. H., Trindade, V. G. S., Luo, S., Orjala, J., & Crnkovic, C. M. (2024) · Natural Product Reports · doi:10.1039/d4np00040d · Cited by 36
Kang, H., Krunić, A., & Orjala, J. (2012) · Journal of Natural Products · doi:10.1021/np300150h · Cited by 31
Therapeutic potential of marine peptides in cervical and ovarian cancers
Ahmed, S., Khan, H. Z., Fakhri, S., Aschner, M., & Cheang, W. S. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04306-y · Cited by 24
Matthew, S., Ratnayake, R., Becerro, M. A., Ritson‐Williams, R., Paul, V. J., & Luesch, H. (2010) · Marine Drugs · doi:10.3390/md8061803 · Cited by 24
Self-citationKohamamides A, B, and C, Cyclic Depsipeptides from an Okeania sp. Marine Cyanobacterium
Iwasaki, A., Shiota, I., Sumimoto, S., Matsubara, T., Sato, T., & Suenaga, K. (2017) · Journal of Natural Products · doi:10.1021/acs.jnatprod.7b00256 · Cited by 23
Maedamide, a novel chymotrypsin inhibitor from a marine cyanobacterial assemblage of Lyngbya sp.
Iwasaki, A., Ohno, O., Sumimoto, S., Suda, S., & Suenaga, K. (2014) · Tetrahedron Letters · doi:10.1016/j.tetlet.2014.05.099 · Cited by 21
Iwasaki, A., Sumimoto, S., Ohno, O., Suda, S., & Suenaga, K. (2014) · Bulletin of the Chemical Society of Japan · doi:10.1246/bcsj.20140008 · Cited by 21
Structural Diversity and Biological Activity of Cyanopeptolins Produced by Nostoc edaphicum CCNP1411
Konkel, R., Cegłowska, M., Szubert, K., Wieczerzak, E., Iliakopoulou, S., Kaloudis, T., & Mazur‐Marzec, H. (2023) · Marine Drugs · doi:10.3390/md21100508 · Cited by 21
Stictamides A−C, MMP12 Inhibitors Containing 4-Amino-3-hydroxy-5-phenylpentanoic Acid Subunits
Liang, Z., Sorribas, A., Sulzmaier, F. J., Jiménez, J. I., Wang, X., Sauvage, T., Yoshida, W. Y., Wang, G., Ramos, J. W., & Williams, P. G. (2011) · The Journal of Organic Chemistry · doi:10.1021/jo200241h · Cited by 20
Vegman, M., & Carmeli, S. (2013) · Tetrahedron · doi:10.1016/j.tet.2013.09.054 · Cited by 19
Kanamori, Y., Iwasaki, A., Sumimoto, S., & Suenaga, K. (2016) · Tetrahedron Letters · doi:10.1016/j.tetlet.2016.08.012 · Cited by 19
Nicholson, G. M., & Clements, K. D. (2023) · Biological Journal of the Linnean Society · doi:10.1093/biolinnean/blad005 · Cited by 17
Tan, L. T. (2012) · Studies in natural products chemistry · doi:10.1016/b978-0-444-53836-9.00021-9 · Cited by 18
Pettit, G. R., Smith, T. H., Xu, J., Herald, D. L., Flahive, E. J., Anderson, C. R., Belcher, P. E., & KNIGHT, J. C. (2011) · Journal of Natural Products · doi:10.1021/np100877h · Cited by 17
Cyanobacteria derived compounds: Emerging drugs for cancer management
Shahid, A., Khurshid, M., Aslam, B., Muzammil, S., Mehwish, H. M., Rajoka, M. S. R., Hayat, H. F., Sarfraz, M. H., Razzaq, M. K., Nisar, M. A., et al. (2021) · Journal of Basic Microbiology · doi:10.1002/jobm.202100459 · Cited by 19
“Furthermore, depsipeptide inhibitor that is, molassamide is also responsible to hinder the normal function of elastase [42].”
BackgroundSpiers, L. J., Harrison, S. J., Deutsch, J. M., Garg, N., & Paul, V. J. (2021) · Aquatic Ecology · doi:10.1007/s10452-021-09873-2 · Cited by 14
Self-citationSynthesis and Pharmacological Studies on a Cyclooligopeptide from Marine Bacteria
Dahiya, R., & Gautam, H. (2011) · Chinese Journal of Chemistry · doi:10.1002/cjoc.201180333 · Cited by 14
Computational Approaches to Enzyme Inhibition by Marine Natural Products in the Search for New Drugs
Gago, F. (2023) · Marine Drugs · doi:10.3390/md21020100 · Cited by 13
A thermostable trypsin inhibitor with antiproliferative activity from small pinto beans
Chan, Y. S., Zhang, Y., Sze, S. C. W., & Ng, T. B. (2013) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2013.805756 · Cited by 12
Seasonal dynamics of chemotypes in a freshwater phytoplankton community – A metabolomic approach
Sadler, T., Kuster, C. J., & von Elert, E. (2014) · Harmful Algae · doi:10.1016/j.hal.2014.07.006 · Cited by 12
Cyanobacteria as a Biocontrol Agent
Yadav, P., Singh, R. P., Patel, A. K., Pandey, K. D., & Gupta, R. K. (2022) · Springer eBooks · doi:10.1007/978-3-030-87289-2_6 · Cited by 14
Rauf, A., Khalil, A. A., Olatunde, A., Khan, M., Anwar, S., Alafnan, A. D., & Rengasamy, K. R. R. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105521 · Cited by 11
Cyanobacteria as Valuable Tool in Biotechnology
Śliżewska, A., & Żymańczyk–Duda, E. (2021) · Catalysts · doi:10.3390/catal11111259 · Cited by 13
“molassamide Dichothrix utahensis [65] anabaenopeptin NZ 857 Nostoc punctiforme PCC 73102 [66] nostamide A Nostoc punctiforme PCC 73102 [66] anabaenopeptin A, B, C Anabaena sp.”
BackgroundChen, Q.-Y., Luo, D., Seabra, G. D. M., & Luesch, H. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115756 · Cited by 10
Self-citationCyanobacteria: a potential source of anticancer drugs
Mehta, A., Soni, V. K., Shukla, D., & Vishvakarma, N. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819311-2.00024-3 · Cited by 10
Marine Cyanobacteria Compounds with Anticancer Properties: Implication of Apoptosis
Martins, M. D. R., & Costa, M. (2014) · Springer eBooks · doi:10.1007/978-3-319-07145-9_29 · Cited by 10
Other Cyanobacterial Bioactive Substances
Eleršek, T., Bláha, L., Mazur‐Marzec, H., Schmidt, W., & Carmeli, S. (2016) · Wiley eBooks · doi:10.1002/9781119068761.ch19 · Cited by 11
Zhioua, S., Khan, I., González, D., Junier, P., & Sieber, S. (2025) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2025.179750 · Cited by 6
Trends in the enzymatic inhibition by natural extracts
Ávila-Alvarez, K. T., Chávez‐González, M. L., Segura-Ceniceros, E. P., Martínez‐Hernández, J. L., Arredondo-Valdés, R., Govea‐Salas, M., Nava-Reyna, E., Ilyina, A. D., & Ramos‐González, R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89929-1.00030-5 · Cited by 7
O’Brien, S., Alvariño, R., Kennedy, B., Botana, L. M., & Thomas, O. (2024) · Phytochemistry · doi:10.1016/j.phytochem.2024.114137 · Cited by 4
Marine cyanobacteria: A prolific source of antimicrobial natural products
Sivakumar, N., & Selvakumar, G. (2015) · CRC Press eBooks · doi:10.1201/b19224-14 · Cited by 4
Chauvin, I. M., Davis, L. J., Krunić, A., & Orjala, J. (2026) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5c01413 · Cited by 3
“It also confirmed the presence of known metabolites being produced, aiding in dereplication.”
Bhattacharjee, A., Chakraborty, R., & Sen, S. (2021) · Springer eBooks · doi:10.1007/978-981-15-8127-4_8 · Cited by 3
Protease inhibitors from marine organisms
Karthik, L., & Kirthi, A. V. (2015) · CRC Press eBooks · doi:10.1201/b19224-12 · Cited by 2
Uncovering chemical novelty from freshwater filamentous Cyanobacteria
Weiss, M. B., Yoon, J., Domingues, J. P. B., Jacinavicius, F. R., Freire, V. F., Domingos, H. V., de Moraes, M. O., Gonçalves, C. M. C., Castro, S. R., Lindoso, J. A. L., et al. (2025) · Fitoterapia · doi:10.1016/j.fitote.2025.107055 · Cited by 1
Wang, X., Tan, Y., Yang, Y., Yu, H., Cheng, J., Zhang, Z., Song, C. M., Zhang, Y., & Yin, Y. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c03103 · Cited by 2
The Nobilamides: Potent Biofilm Inhibitors Produced by the Microbiota of Moon Snail Egg Masses
Kyei, L., Campbell, R., Menegatti, C., & Mevers, E. E. (2025) · ACS Omega · doi:10.1021/acsomega.5c01534 · Cited by 1
New bioactive secondary metabolites from cyanobacteria
Liu, L. (2014) · Työväentutkimus Vuosikirja · Cited by 3
Molecular Targets of Clinically Relevant Natural Products from Filamentous Marine Cyanobacteria
Tan, L. T. (2017) · Wiley eBooks · doi:10.1002/9783527805921.ch2
Kornprobst, J. (2014) · Wiley eBooks · doi:10.1002/9783527335855.marprod008
Antioxidant, Anti-Inflammatory and Anticancer Peptides from Extreme Marine Environments
Zakariya, M., Montuori, E., Kopp, G., Coppola, A., Giordano, D., Bruno, S., & Lauritano, C. (2026) · Antioxidants · doi:10.3390/antiox15050615 · Cited by 3
“An analogue of dolastatin 13, molassamide, which contains 6 common amino acids (Val-N-Me-Tyr-Phe-Ahp-Abu-Thr), was isolated from a cyanobacterial assemblage of Di-chothrix utahensis collected from Florida and showed protease-inhibition activity against elastase with IC 50 value of 0.032 µ M [118].”
InfluentialEditorial Introducing the Collection in Honor of Valerie J. Paul
Luesch, H., & Fenical, W. (2026) · Journal of Natural Products · doi:10.1021/acs.jnatprod.6c00688
Self-citation
Metadata
- Authors
- Gunasekera, S. P., Miller, M. W., Kwan, J. C., Luesch, H., & Paul, V. J.
- Affiliations
- National Oceanic and Atmospheric Administration (US)
- Corresponding author
- Paul, Valerie J.
- Venue
- Journal of Natural Products
- Publisher
- American Chemical Society (ACS)
- Published
- 2009-12-18
- Volume
- 73
- Issue
- 3
- Pages
- 459-462
- ISSN
- 0163-3864 (ISSN-L)
- 1520-6025
- OpenAlex
- W2001056221
- Cited by
- 75
- References
- 16
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 3 · 2023: 5 · 2022: 5 · 2021: 7 · 2020: 6 · 2019: 5 · 2018: 1 · 2017: 3 · 2016: 1 · 2015: 3 · 2014: 8 · 2013: 5 · 2012: 5
- FWCI
- 3.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Natural Products (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Marine Sponges and Natural Products
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Keywords
- depsipeptides, serine protease inhibitors, marine cyanobacteria, natural product isolation, structure elucidation, elastase inhibition, chymotrypsin inhibition, trypsin
- MeSH terms
- Cyanobacteria, Animals, Marine Biology, Oligopeptides, Pancreas, Pancreatic Elastase, Swine, Molecular Structure, Serine Proteinase Inhibitors, Inhibitory Concentration 50, Depsipeptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.